Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hongyao She"'
Autor:
Jeffrey W. Johannes, Fiona Pachl, Amber Balazs, Tieguang Yao, C. Larner, Lisa McWilliams, Marianne Schimpl, Scott W. Martin, Kevin J. Embrey, Tom D. Heightman, Paul Hemsley, Jonathan P. Orme, Derek Barratt, Giuditta Illuzzi, Andrew Madin, Paolo Di Fruscia, Avipsa Ghosh, Martin J. Packer, Scott D. Edmondson, Elisabetta Leo, Xiaolan Zheng, Matthew D. Chuba, Xiaohui Pei, Mark J. O'Connor, Verity Talbot, Ke Zhang, Stephen Fawell, Elizabeth Underwood, Anna Staniszewska, Lina Liu, Lin Xue, Sonja J. Gill, Anders Gunnarsson, Andrew Pike, Susan E. Critchlow, Jeffrey G. Varnes, Andrew X. Zhang, Sébastien L. Degorce, J. Lane, Sudhir M. Hande, Hongyao She, Sabina Cosulich, Michal Bista
Publikováno v:
Journal of Medicinal Chemistry. 64:14498-14512
Poly-ADP-ribose-polymerase (PARP) inhibitors have achieved regulatory approval in oncology for homologous recombination repair deficient tumors including BRCA mutation. However, some have failed in combination with first-line chemotherapies, usually
Autor:
Jeffrey W, Johannes, Amber, Balazs, Derek, Barratt, Michal, Bista, Matthew D, Chuba, Sabina, Cosulich, Susan E, Critchlow, Sébastien L, Degorce, Paolo, Di Fruscia, Scott D, Edmondson, Kevin, Embrey, Stephen, Fawell, Avipsa, Ghosh, Sonja J, Gill, Anders, Gunnarsson, Sudhir M, Hande, Tom D, Heightman, Paul, Hemsley, Giuditta, Illuzzi, Jordan, Lane, Carrie, Larner, Elisabetta, Leo, Lina, Liu, Andrew, Madin, Scott, Martin, Lisa, McWilliams, Mark J, O'Connor, Jonathan P, Orme, Fiona, Pachl, Martin J, Packer, Xiaohui, Pei, Andrew, Pike, Marianne, Schimpl, Hongyao, She, Anna D, Staniszewska, Verity, Talbot, Elizabeth, Underwood, Jeffrey G, Varnes, Lin, Xue, Tieguang, Yao, Ke, Zhang, Andrew X, Zhang, Xiaolan, Zheng
Publikováno v:
Journal of medicinal chemistry. 64(19)
Poly-ADP-ribose-polymerase (PARP) inhibitors have achieved regulatory approval in oncology for homologous recombination repair deficient tumors including BRCA mutation. However, some have failed in combination with first-line chemotherapies, usually